A biotech company wants to replace decades-long cholesterol-lowering treatments with a one-time procedure. It involves editing people’s DNA https://t.co/Oq8NPiSmsj via @BW— Bloomberg (@business) May 6, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


